“Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma” (2022) SKIN The Journal of Cutaneous Medicine, 6(2), pp. 109–121. doi:10.25251/skin.6.2.4.